+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 40Years +
MALE
Healthy Volunteers
ID07848828

Study of Nervous System and Kidney Effects on Blood Pressure in Men Using Androgen Deprivation Therapy for Prostate Cancer

Led by Virginia Commonwealth University · Updated on 2026-11-02

60

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how androgen deprivation therapy ADT, a common treatment for prostate cancer in men, may contribute to the development of high blood pressure and heart disease. The study focuses on understanding whether problems in the nervous system or kidneys occur in men undergoing ADT, as these organs are important in controlling blood pressure. This research aims to improve knowledge about the link between ADT and heart disease risk in prostate cancer survivors. Participants will be assigned to one of three groups men with prostate cancer receiving ADT gonadotropin releasing hormone agonist plus androgen receptor inhibitor, healthy men undergoing the same ADT treatment for 9 weeks, or healthy men receiving a placebo for 9 weeks. The treatments include 8 weeks of GnRH agonist and 2 weeks of androgen receptor inhibitor for the ADT groups. The study uses a randomized, triple-blinded design with parallel groups to compare the effects of these interventions. During the study, participants will undergo various tests before and after 9 weeks of treatment or placebo, including measures of blood pressure response, nervous system reflexes, kidney function, and injury biomarkers. These include cardiovagal baroreflex sensitivity, blood pressure reactivity to cold, exercise pressor reflex, ambulatory and beat-to-beat blood pressure variability, renal vascular resistance, and kidney injury markers. The study will track changes in these outcomes to assess how ADT affects blood pressure control and kidney health over the treatment period.

CONDITIONS

Brief Title

Autonomic and Renal Contributions to Hypertension With ADT

Research Team

M

Matthew Babcock, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here